Comparación de las tablas REGICOR y SCORE para la clasificación del riesgo cardiovascular y la identificación de pacientes candidatos a tratamiento hipolipemiante o antihipertensivo

  • Buitrago Ramírez F
  • Cañón-Barroso L
  • Díaz-Herrera N
 et al. 
  • 27


    Mendeley users who have this article in their library.
  • 28


    Citations of this article.


Introduction and objectives. In Spain, use of the Framingham-REGICOR (Registre Gironí del Cor) and SCORE (Systematic Coronary Risk Evaluation) risk charts is recommended for stratifying cardiovascular disease risk. The aims of the present study were to evaluate the degree of agreement between these charts when used to evaluate cardiovascular disease risk in nondiabetic individuals aged 40-65 years and to estimate the percentage of patients recommended for hypolipidemic or antihypertensive treatment. Methods. The study included 608 nondiabetic patients aged between 40-65 years (mean 52.8 years, 56.7% female) with no evidence of cardiovascular disease who were attending a primary healthcare center between 190-1994. REGICOR and SCORE equations were used to calculate 10-year cardiovascular disease risks. Patients were classified as high-risk if their risk was ≥10% with REGICOR or ≥5% with SCORE. Results. Some 7.9% of the population was classified as high-risk with REGICOR and 9.2%, with SCORE (P=.41). Only 2.6% and 2.9% (P=.81) of women were classified as high-risk, compared with 14.8% and 17.5% of men, with REGICOR and SCORE, respectively (P=.40). The kappa coefficient was 0.45. According to European professional society guidelines, 23.8% of patients classified by SCORE and 23.0% classified by REGICOR (P=.73) would be recommended hypolipidemic treatment, while 31.2% and 31.7% (P=.85), respectively, would be recommended antihypertensive treatment. Conclusions. There was moderately good agreement between REGICOR and SCORE charts when used to evaluate nondiabetic individuals aged 40-65 years. They identified similar percentages of patients who would be recommended for hypolipidemic or antihypertensive treatment.

Author-supplied keywords

  • Cardiovascular risk
  • Coronary risk
  • REGICOR risk chart
  • SCORE risk chart

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Francisco Buitrago Ramírez

  • Lourdes Cañón-Barroso

  • Natalio Díaz-Herrera

  • Eloísa Cruces-Muro

  • Miguel Escobar-Fernández

  • José M. Serrano-Arias

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free